Skip to main content
. Author manuscript; available in PMC: 2018 Oct 5.
Published in final edited form as: Am J Prev Med. 2017 Dec;53(6 Suppl 2):S155–S163. doi: 10.1016/j.amepre.2017.06.012

Table 1.

Intervention characteristics

Intervention of
interest
Number of Studies in
economic review
Target
population
Who
implements?
Risk Factor Focus Additional interventions
combined with the intervention
of interest and percent of
studies with that combination*
Team-based
care (TBC)
31 Healthcare
providers and
patients
Healthcare
system
High BP CDSS 10%
Disease registry 6%
SMBP 13%
ROPC or VBID 6%
Case management 3%
Reduced out
of pocket cost
(ROPC)
9 Patients Health
insurance plan
Adherence to treatment for
High BP and Dyslipidemia
TBC 22%
Disease management 22%
Clinical
decision
support
systems (CDSS)
21 Healthcare
providers
Clinics High BP,
Dyslipidemia,
Diabetes, Smoking,
Physical activity, Nutrition
TBC 24%
Provider incentives 9%
Provider audit and feedback 5%
Patient phone reminders or report to patient 28%
Quality improvement 38%
Self-measured
blood pressure
monitoring
(SMBP)
22 grouped into three
categories*
•SMBP alone 8
•SMBP with spport 8
•SMBP within team-based care 8
Patients and
healthcare
providers
Patient or
Health
insurance plan
High BP Patient support 36%
TBC 36%
Community
health workers
(CHW)
4 Healthcare
providers and
patients
Healthcare
system
High BP,
Dyslipidemia,
Smoking, Physical
activity, Nutrition
TBC 100%
*

Studies are not mutually exclusive

BP, blood pressure; SMBP, self-measured blood pressure; VBID – value-based insurance design